Retinoblastoma Latest Advances

Selective CDK2 Degradation via Noncanonical Recruitment.

Journal: Journal of medicinal chemistry

Published: June 23, 2026

Choroidal coloboma masquerading as regressed retinoblastoma.

Journal: BMJ case reports

Published: June 23, 2026

High-Dose Intravitreal Topotecan Combined With Focal Consolidation Therapy for Recurrent Retinal Tumors in Retinoblastoma.

Journal: Journal of vitreoretinal diseases

Published: June 22, 2026

Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

Journal: Science translational medicine

Published: June 17, 2026

Comparison of the rate of complications in primary and secondary enucleation in patients with retinoblastoma.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: June 09, 2026

Non-Genetic Mechanisms of Fractional Resistance to Abemaciclib in Dedifferentiated Liposarcoma.

Journal: bioRxiv : the preprint server for biology

Published: June 05, 2026

Granular Fluorescein Flow in Retinoblastoma.

Journal: JAMA ophthalmology

Published: June 04, 2026

Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre.

Journal: The National medical journal of India

Published: June 04, 2026

Orbital Fungating Mass as a Rare Manifestation of Retinoblastoma: A Case Study in Palliative Care.

Journal: The American journal of case reports

Published: May 29, 2026

Abemaciclib Inhibits Retinoblastoma Tumor Growth by Targeting CDK1/2.

Journal: Investigative ophthalmology & visual science

Published: May 29, 2026

Post-laminar optic nerve invasion in the presence of scleral invasion: Case for intensive adjuvant treatment in retinoblastoma.

Journal: Indian journal of ophthalmology

Published: May 27, 2026

Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomide.

Journal: Neuro-oncology advances

Published: May 18, 2026

Retinoblastoma Latest Advances

Find the Latest Research About Retinoblastoma

Selective CDK2 Degradation via Noncanonical Recruitment.

Selective CDK2 Degradation via Noncanonical Recruitment.

Choroidal coloboma masquerading as regressed retinoblastoma.

Choroidal coloboma masquerading as regressed retinoblastoma.

High-Dose Intravitreal Topotecan Combined With Focal Consolidation Therapy for Recurrent Retinal Tumors in Retinoblastoma.

High-Dose Intravitreal Topotecan Combined With Focal Consolidation Therapy for Recurrent Retinal Tumors in Retinoblastoma.

Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

Comparison of the rate of complications in primary and secondary enucleation in patients with retinoblastoma.

Comparison of the rate of complications in primary and secondary enucleation in patients with retinoblastoma.

Non-Genetic Mechanisms of Fractional Resistance to Abemaciclib in Dedifferentiated Liposarcoma.

Non-Genetic Mechanisms of Fractional Resistance to Abemaciclib in Dedifferentiated Liposarcoma.

Granular Fluorescein Flow in Retinoblastoma.

Granular Fluorescein Flow in Retinoblastoma.

Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre.

Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre.

Orbital Fungating Mass as a Rare Manifestation of Retinoblastoma: A Case Study in Palliative Care.

Orbital Fungating Mass as a Rare Manifestation of Retinoblastoma: A Case Study in Palliative Care.

Abemaciclib Inhibits Retinoblastoma Tumor Growth by Targeting CDK1/2.

Abemaciclib Inhibits Retinoblastoma Tumor Growth by Targeting CDK1/2.

Post-laminar optic nerve invasion in the presence of scleral invasion: Case for intensive adjuvant treatment in retinoblastoma.

Post-laminar optic nerve invasion in the presence of scleral invasion: Case for intensive adjuvant treatment in retinoblastoma.

Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomide.

Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomide.